CIK 0001357459 · Non-accelerated filer<br>Smaller reporting company
PALISADE BIO, INC.
Sign in to watch- Ticker
- PALI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 522007292
- Phone
- (858) 704-4900
- Business address
- 7750 EL CAMINO REAL, SUITE 5200, CARLSBAD, CA, 92009
- Former names
- PALISADE BIO, INC., Seneca Biopharma, Inc., Neuralstem, Inc.
- Open-market buys, last 90 days
- $28,800
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$28,800. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-06 | Finley John David CEO, CFO, Director | Grant or award · Common Stock Purchase Option | +57,200 | 57,200 | ||
| 2023-01-03 | Finley John David Chief Executive Officer | Grant or award · Restricted Stock Units | +5,236 | 5,236 | ||
| 2022-09-01 | Finley John David Chief Financial Officer | Purchase | +19,481.24 | $0.14 | $3K | 148,727.24 |
| 2022-08-23 | Finley John David Chief Financial Officer | Purchase | +7,350 | $0.16 | $1K | 129,246 |
| 2022-08-16 | Hallam Thomas Chief Executive Officer | Purchase | +40,000 | $0.25 | $10K | 57,592 |
| 2022-08-16 | Hallam Thomas Chief Executive Officer | Purchase · Series 1 Common Stock Purchase Warrant | +40,000 | 40,000 | ||
| 2022-08-16 | Hallam Thomas Chief Executive Officer | Purchase · Series 2 Common Stock Purchase Warrant | +40,000 | 40,000 | ||
| 2022-08-16 | Finley John David Chief Financial Officer | Purchase | +100,000 | $0.25 | $25K | 121,896 |
| 2022-08-16 | Finley John David Chief Financial Officer | Purchase · Series 1 Common Stock Purchase Warrant | +100,000 | 100,000 | ||
| 2022-08-16 | Finley John David Chief Financial Officer | Purchase · Series 2 Common Stock Purchase Warrant | +100,000 | 100,000 | ||
| 2022-04-29 | Finley John David Chief Financial Officer | Other acquisition | +12,545 | 38,867 | ||
| 2007-03-13 | REGAL ONE CORP 10% owner | Other disposition | −97 | 1,293,814 | ||
| 2007-02-05 | REGAL ONE CORP 10% owner | Other disposition | −500,376 | 1,293,911 |
Page 12 of 12 · 233 trades